Heart disease and erectile dysfunction: scientists look inside pelvic arteries for clues
NCT ID NCT07856199
First seen Oct 02, 2026 · Last updated Oct 02, 2026
Summary
Researchers are studying whether fatty plaque buildup in the internal pudendal arteries, the vessels that supply blood to the penis, is linked to erectile dysfunction in men who have or may have coronary artery disease. Sixty men undergoing a clinically needed coronary angiogram will also receive imaging of their pelvic arteries using intravascular ultrasound and near-infrared spectroscopy. The study measures the amount of lipid-rich plaque in those arteries and compares it with erectile function scores collected within 30 days. The goal is to understand the relationship between pelvic artery disease and erectile problems, and to test whether this imaging approach is safe and technically feasible.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Intravascular ultrasound and near-infrared spectroscopy imaging of the internal pudendal arteries
- What this could lead to
- If a link emerges between pelvic artery plaque and erectile dysfunction, doctors could one day use artery imaging to better understand or predict erectile problems in men with heart disease.
- What could go wrong
- This is a small, single-center exploratory study with 60 men, so it can only show associations, not cause and effect. The imaging procedure carries small risks of artery injury or bleeding, and the findings may not apply to men without coronary artery disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2026
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Male participants aged 18 years or older. 2. Documented or suspected coronary artery disease with a clinical indication for coronary angiography. 3. Coronary IVUS-NIRS evaluation indicated by the treating interventional cardiologist. 4. Sufficient clinical and hemodynamic stability to undergo the additional pudendal evaluation. 5. Favorable pelvic vascular anatomy for selective angiography and safe advancement of the IVUS-NIRS catheter. 6. Ability to complete the IIEF-5 questionnaire and provide information regarding sexual function. 7. Written informed consent specifically for study participation and invasive evaluation of the internal pudendal arteries. 8. Agreement to clinical follow-up by Cardiology and Urology. Exclusion Criteria: 1. Cardiogenic shock, hemodynamic instability, or acute clinical deterioration. 2. Urgent or complicated coronary procedure in which prolonging the procedure would increase risk. 3. Advanced kidney disease or high risk of kidney injury associated with additional contrast administration. 4. Unfavorable iliofemoral or pelvic vascular anatomy for safe evaluation of the internal pudendal arteries. 5. Severe coagulopathy, active bleeding, or contraindication to the invasive procedure. 6. History of radical pelvic surgery or pelvic radiotherapy. 7. Advanced prostate cancer or previous urologic treatment that predominantly explains erectile dysfunction. 8. Severe untreated hypogonadism, advanced neurologic disease, or another predominant nonvascular cause of erectile dysfunction. 9. Inability to reliably complete the IIEF-5 questionnaire. 10. Refusal to participate or to provide study-specific written informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Atherosclerosis are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hospital Central Militar
RECRUITINGMexico City, Mexico City, 11200, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- The COronary REvascularisation platform trial: study master protocol for a platform trial
- Randomized comparison of an ultra-low strut thickness everolimus-eluting biodegradable polymer stent versus durable polymer everolimus-eluting stents in patients treated with percutaneous coronary intervention in an all comer population (The SORT OUT XII trial)
- A prospective multicenter registry study for the optimization of magnetocardiography (MCG) algorithm in patients with Moderate-to-Severe coronary artery stenosis (Derivation phase)
- Nitric oxide-mediated cardioprotection during cardiac surgery with cardiopulmonary bypass
- The utility of (Fractional flow Reserve)FFR before and after successful percutaneous coronary intervention
- Rapid Inflation/Deflation compared with prolonged High-Pressure balloon inflation on the results of stent deployment